Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.
Clinical trial NCT04219241 · UNKNOWN
Trial details
- NCT number
- NCT04219241
- Sponsor
- Azidus Brasil
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2022-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.